Skip to main content
SpringerLink
Log in

Effect of FDA boxed warning on fluoroquinolone stewardship

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bratsman A, et al. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning. Pharmacoepidemiology and Drug Safety : 11 May 2020. Available from: URL: http://doi.org/10.1002/pds.5018

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Effect of FDA boxed warning on fluoroquinolone stewardship. Reactions Weekly 1805, 8 (2020). https://doi.org/10.1007/s40278-020-78718-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78718-z

Search

Navigation